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Conclusion. Treatment time is a factor that could inﬂuence on SBRT uncertainty. In our experience, set-up time is longer the ﬁrst
day of treatment than in the rest of fractions. Dynamic arc therapy is faster than treatment with only ﬁxed ﬁelds. Immobilization
with Bodyﬁx® gives enough accuracy, being our PTV margin of 0.5 cm appropriate according to our data.
http://dx.doi.org/10.1016/j.rpor.2013.03.558
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Purpose. To analyze our experience treating lung tumours with stereotactic body radiation therapy (SBRT), emphasising what
concerns to toxicity.
Materials and methods. We evaluate our results treating patients with stage I lung cancer or lung metastases with SBRT from
August 2011 to December 2012. We describe toxicity using the Common Terminology Criteria for Adverse Events v3.0 (CTCAE).
We evaluate the local control (LC), regional relapse (RR), distant progression (DP) and overall survival (OS).
Results. We have treated eighteen patients in that period with a median age of 74 (54–87). 22% were women and 78% men. The
ECOG performance status was 1 in 72% patients, 2 in 22% and 3 in 5%. Thirteen patients had stage I lung cancer (72%) and ﬁve had
lung metastases (28%). With a median follow up of 6.5 months, 6 patients developed grade 1 pneumonitis (33%) and 2 patients
grade 2 pneumonitis (11%). Two patients had grade 1 chest wall pain. Only one grade 1 dermatitis was observed. The LC was of
100%. Between patients with stage I lung cancer, RR was observed in 6% and DP in 13%. OS was 89%.
Conclusions. With a short median follow-up time our results are coherent with published data, achieving excellent local control
with distant progression as ﬁrst relapse in patients diagnosed of stage I lung cancer. SBRT was well tolerated with no severe
toxicity observed.
http://dx.doi.org/10.1016/j.rpor.2013.03.559
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Background. Stereotactic radiosurgery (SRS) delivers a potent, highly focused dose of radiation to the tumor while sparing the
surrounding normal tissues.
Aim. The purpose of this study is to assess the outcome of patients with intracranial meningiomas treated with SRS.
Methods. A total of 73 patients with 221 benign meningiomas treated with SRS and followed up for more than a year were reviewed
between 1991 and 2005. Fifty patients (68%) were treated with SRS to the primary meningioma while 23 (32%) patients received
SRS to the relapses adjacent or distant from the site of the initial meningioma that was previously treated with surgery alone.
Mean tumor margin dose was 14Gy (range, 10–16). SRS was delivered after surgery in 117 meningiomas (55 patients).
Results. The median age at diagnosis was 47 years old (range, 16–74) and the median follow-up 5.8 years (range, 1–13.6). The 3-
and 5-year overall survival rates for all patients were 95% and 90%, respectively. The mean gross tumor volume decreased from
4.17 cm3 to 3.23 cm3 after SRS (P=0.057). Twenty-two (10%) meningiomas increased after SRS. In addition, clinical symptoms
improved in 36% and remained stable in 45%. With regard to morbidity of SRS, only 7 patients (9.6%) had late complications,
including: edema (N=4), brain necrosis (N=4), gliosis (N=1), and paresis of the III pair (N=1). There was no treatment-related
mortality.
Conclusions. SRS for patients with multiple intracranial meningiomas is effective yielding a high local tumor control, whereas the
treatment-related morbidity remains low.
http://dx.doi.org/10.1016/j.rpor.2013.03.560
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Introduction. Whole-brain radiation therapy (WBRT) combined with boost on the metastases has demonstrated to improve the
results of the treatment in selected patients in contrast to single WBRT.
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Purpose. We retrospectively evaluated it with Elekta Synergy VMAT and a patented system to achieve high quality fusion image
and immobilization.
Methods. The procedure improved thermoplastic immobilization by means of a sub-mask (eXaSkin by Anatomical-Geometry). A
similar number of CT and axial magnetic resonance images were acquired with the same immobilization. It is possible using
eXaFrame system. The treatment was designed with the inverse module for VMAT of Pinnacle v.9.2 (SmartArc), with multiple arcs
performed with Elekta Synergy. The dose scheme employed is the Lagerwaard one: [WBRT (20Gy) +SIBmts (40Gy)]/5 frac . Daily
patient positioning was checked with IGRT (Elekta XVI). First step is WBRT: two arcs VMAT CCW (178–60◦ and 300–182◦) with the
following objectives: brain (Dmax=21Gy, weigh=100 and Dmin=20Gy, weigh=50), eyes (Dmax=10Gy, weigh=1). Later on, we
focused on metastases separately: we block the optimization prophylaxis (Optimization Type None) and create three structures:
VI1 =PTV (mts1) + 5mm, VI2=PTV (mts2) + 5mm, Epx=encéfalo-VI1-VI2. The objectives were: PTVi (Dmax=44Gy, weigh=100
and Dmin=40Gy weigh=50), Epx (Dmax=30Gy) and brain stem (Dmax=23Gy). Treatment veriﬁcation was performed with the
Compass-Matrixx system.
Results. Until now we have treated 11 patients, being the differences in fusion images less than 1mm and mean IGRT correction
of 1.24mm. No acute toxicity and hair problems. Of the 11 patients treated 7 are alive without brain progression or neurological
toxicities, 3 died after systemic progression of the disease and 1 of them because of complications associated with systemic
treatment. Total time spent on the process, including contouring, treatment design and veriﬁcation, without considering the
learning curve, is about 7h.
Conclusions. Hypofractionated stereotactic radiotherapy with eXaFrame and eXaSkin in patients with up to three brain metas-
tases with IGRT and VMAT is a workable solution. It’s a rapid and accurate technique that has a higher conformity index than
conventional summation of WBRT and radiosurgery boost.
http://dx.doi.org/10.1016/j.rpor.2013.03.561
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Introduction. The swannomas are benign tumors of neural tissue that can be treated with surgery, radiosurgery or FSRT.
Objective. Analyze the results of auditory toxicity and treatment complications of vestibular schwannomas at our institution.
Materials and methods. Between 2004 and 2011, 95 patients have been evaluated for treatment with FSRT, with a median age of
57 years. Tumor size was less than 1 cm in 14.7% of patients, between 1 and 1.99 cm in 35.8%, between 2 and 2.99 cm in 33.7%,
between 3 and 3.99 cm in 9.5% and greater than 4 cm in 6.3%. The hearing before treatment was normal in 4.2%, with loss of
less than 30dB in 52.6%, greater than 30dB loss in 25.3% and deafness in 17.9%. 80.9% of patients had not undergone surgery,
while 14.9% they were been intervened once and 4.3% twice. Balance remained intact in 63.2% of patients with mild disease in
25.3% and severe in 11.6%. Matthies classiﬁcation: 23.2% of patients were T1, 26.1% T2, 31.9% T3 and 18.8% T4. The treatment
has been performed in 72 of the 95 patients evaluated, excluding those who lacked the teeth necessary for inmovilization with
the Gill–Thomas–Cossman’s guide. The therapy has been performed with cone in 83.3% of patients and with multileaf in 16.7%.
The median dose was 54.78Gy with a median treatment duration of 42 days.
Results. Hearing after FSRT remained unchanged in 81.9% of patients, improved in 4.2% and worsened in 13.9%. Most patients
had no complications (95.8%), with edema of trunk in 1 patient and radiation necrosis in 2 patients. Complications ocurred in
patients who had previously been operated.
Conclusion. FSRT is an effective treatment in vestibular swannomas with hearing preservation greater than surgery, and with low
complication rate.
http://dx.doi.org/10.1016/j.rpor.2013.03.562
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Introduction. Trigeminal neuralgia (TN) incidence is 4.5/100,000 and is highly disabling. Most cause of the classical (idiopathic
or essential) is vascular. 30 years ago a Spanish center performed the ﬁrst treatment of TN (Dr Larrea). The SRS is used when
medication or other methods are not effective. SRS is also used in patients with medical co-morbidities.
Objectives. Demand arising in our center led to commissioning and ﬁrst 5 pilot cases at Meixoeiro (CHUVigo) as described below.
